1991Acta OphthalmologicaRequires access

Topical indomethacin for vernal keratoconjunctivitis

Seema Gupta, Ashi Khurana, B. K. Ahluwalia, Nitin Gupta

Open publisher page 15 citations

Abstract

Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.

About this research paper

What this paper is about

Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.

Key concepts: Vernal keratoconjunctivitis, Keratoconjunctivitis, Medicine, Ophthalmology, Dermatology, Allergic conjunctivitis, KERATOCONJUNCTIVITIS SICCA, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Topical indomethacin for vernal keratoconjunctivitis — Research Paper | ScholarLens